Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s00705-020-04860-8 http://scihub22266oqcxt.onion/10.1007/s00705-020-04860-8 33136210!7604546!33136210     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33136210&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Arch+Virol 2021 ; 166 (1): 1-7 Nephropedia Template TP {{tp|p=33136210|t=2021. Tetracycline and viruses: a possible treatment for COVID-19?|pdf=|usr=}}{{33136210}} gab.com Text Tetracycline and viruses: a possible treatment for COVID-19 JO: Arch Virol http://www.kidney.de/pget.php?&tw=1&pmid=33136210 #FOAvip Tetracyclines have been used to treat many bacterial infections. The use of these antibiotics for the treatment of viral diseases dates to the 1960s to 1970s. Over the decades, the effect of tetracyclines on the pathogenesis of viral infections has been demonstrated both clinically and experimentally. Tetracyclines can act on viral infections either through their antibacterial properties or through direct antiviral action. This review focuses on clinical and experimental data that support the use of tetracycline in treating viral infections and highlights an important approach to slowing disease progression during viral infections. Tetracycline treatment might represent a strategy for eliminating the infection or inhibiting the progression of COVID-19. Twit Text FOAVip Tetracycline and viruses: a possible treatment for COVID-19 ????Arch Virol http://www.kidney.de/pget.php?&tw=1&pmid=33136210 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33136210 #FOAvip English Wikipedia <ref>{{Cite pmid|33136210}}</ref> Tetracycline and viruses: a possible treatment for COVID-19? #MMPMID33136210 Mosquera-Sulbaran JA; Hernandez-Fonseca H Arch Virol 2021[Jan]; 166 (1): 1-7 PMID33136210show ga Tetracyclines have been used to treat many bacterial infections. The use of these antibiotics for the treatment of viral diseases dates to the 1960s to 1970s. Over the decades, the effect of tetracyclines on the pathogenesis of viral infections has been demonstrated both clinically and experimentally. Tetracyclines can act on viral infections either through their antibacterial properties or through direct antiviral action. This review focuses on clinical and experimental data that support the use of tetracycline in treating viral infections and highlights an important approach to slowing disease progression during viral infections. Tetracycline treatment might represent a strategy for eliminating the infection or inhibiting the progression of COVID-19. |*COVID-19 Drug Treatment[MESH] |Anti-Bacterial Agents/therapeutic use[MESH] |Anti-Inflammatory Agents/*therapeutic use[MESH] |Antiviral Agents/*therapeutic use[MESH] |Apoptosis/drug effects[MESH] |Disease Progression[MESH] |Humans[MESH] |SARS-CoV-2/*drug effects[MESH]Tetracycline and viruses: a possible treatment for COVID-19?(epmc).pdf DeepDyve Pubget Overpricing